| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |